Skip to Main Content

Paper Details

Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer.
Clin Cancer Res
17
2022
Lung Cancer, OligoAR, PD-(L)1, PD-L1, metastatic lung cancer, oligoAR, patient, patients, tumor
Author NameAffiliation
Hira RizviDruckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center
Danish MemonEuropean Bioinformatics Institute
Danish MemonCancer Research UK Cambridge Institute, University of Cambridge
Chiaojung Jillian TsaiMemorial Sloan Kettering Cancer Center
Jayon LihmMemorial Sloan Kettering Cancer Center
Benjamin D GreenbaumMemorial Sloan Kettering Cancer Center
Gregory J RielyMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Charles M RudinMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Charles M RudinDruckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center
Daniel R GomezMemorial Sloan Kettering Cancer Center
  • 1 - 10

Datasets

Release 1.2